Open access · OA
via Europe PMC
NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target.
Tenreiro S, Falcão AS, Bender N, Bernatova I, Berry A, Cuadrado A, Eppenberger P, Giona L, Grochot-Przeczek A, Heiss E, Jakubowska M, Long PF, Makhro A, Masoodi M, Morgenstern C
Redox biology · 2026
Abstract
NRF2 (Nuclear Factor Erythroid 2-Related Factor 2) has traditionally been viewed as a master regulator of the antioxidant response. However, emerging evidence redefines NRF2 as a pleiotropic and evolutionarily conserved systems-level integrator of redox, metabolic, proteostatic, and inflammatory homeostasis, i.e., an evolutionarily conserved guardian of health. From its origins as an adaptive response to rising atmospheric oxygen in early metazoans to its role in orchestrating complex cytoprotective networks in humans, NRF2 exemplifies the biological transition from stress resistance to adaptive resilience. Understanding its regulation across species, tissues, life stages and gender offers novel perspectives for combating age-related cellular dysfunction and reframing the dynamic process of redox regulation as a component of adaptive homeostasis in a precision medicine perspective. This review summarizes and integrates essential concepts currently being developed regarding the evolutionary roots of NRF2, its molecular and regulatory complexity, its dualistic role in health and disease, and its potential as a biomarker of resilience and therapeutic target. We highlight NRF2's function as a rheostat rather than a binary stress switch, including the role of hormetic activation through lifestyle and environmental stimuli. By maintaining redox homeostasis and dynamic adaptive stress responses, NRF2 bridges molecular defense mechanisms with strategies for healthspan(definition) extension and preventive medicine from very early life stages until senescence(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.redox.2026.104217
- Canonical
- link ↗
- Fetched
- 2026-06-01 MST
Cite this
APA
S, T., AS, F., N, B., I, B., A, B., A, C., P, E., L, G., A, G., E, H., M, J., PF, L., A, M., M, M., C, M., L, S., MC, S., A, S., G, S., & IP., T. (2026). NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target. <em>Redox biology</em>. https://doi.org/10.1016/j.redox.2026.104217
Vancouver
S T, AS F, N B, I B, A B, A C, et al. NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target. Redox biology. 2026. doi:10.1016/j.redox.2026.104217.
BibTeX
@article{tenreiro2026NRFasa,
title = {NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target.},
author = {Tenreiro S and Falcão AS and Bender N and Bernatova I and Berry A and Cuadrado A and Eppenberger P and Giona L and Grochot-Przeczek A and Heiss E and Jakubowska M and Long PF and Makhro A and Masoodi M and Morgenstern C and Saso L and Seabra MC and Sznarkowska A and Sykiotis G and Trougakos IP.},
journal = {Redox biology},
year = {2026},
doi = {10.1016/j.redox.2026.104217},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular and Cellular Biochemistry 2023
Open access · CC-BY
NRF2 signaling pathway and telomere length in aging and age-related diseases
Cureus 2025
Open access · OA
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.
Cold Spring Harbor Perspectives in Biology 2011
Open access · OA
Quality Control of Mitochondrial Proteostasis
The Journal of Cell Biology 2017
Open access · OA
Senescence and aging: Causes, consequences, and therapeutic avenues
Trends in Plant Science 2000
Preprint · OA
Molecular aspects of leaf senescence
Cardiovascular Research 2024
Open access · OA